Harvard firm designs $37M Marlborough manufacturing plant
Courtesy Maugel Architects Inc.
At its new facility on Crowley Drive, LFB USA will produce the drug ATryn, which is used to treat preeclampsia.
Maugel Architects of Harvard announced Monday it designed a $37-million biomanufacturing facility in Marlborough for a French biopharmaceutical firm.
At its new facility on Crowley Drive, LFB USA, a unit of France’s LFB Group, will produce the drug ATryn, which is used to treat preeclampsia, a leading cause of maternal and infant death. The 70,000-square-foot facility will have 30,000 square feet of cleanroom manufacturing space, 20,000 square feet of warehouse space, and 14,000 square feet of office space.
Leominster-based Whitman & Bingham Associates, TF Moran, Inc. of Bedford, N.H., Worcester-based William F. Lynch Co., Inc., Worcester-based Shepherd Engineering, Marlborough-based SNC-Lavalin Project Services and Boylston-based R.P. Masiello all worked with Maugel on the project.
Construction in biomanufacturing is booming, as the industry grows at the highest rate of any subsector tracked by the Massachusetts Biotechnology Council.
WBJ Web Partners
Most Recent
Most Recent
0 Comments